Committee
Consult the user guide
For assistance, please contact us
Consult the user guide
For assistance, please contact us
Add search criteria
Results: 1 - 1 of 1
View Matt Jeneroux Profile
CPC (AB)
Thank you, Mr. Chair.
Since October 2019, 25 new medicines have been launched in the United States and none of them have been submitted to Health Canada. The PMPRB regulatory changes require reductions of up to 90% for some new therapies, especially for rare disorders. There is some concern that these changes are keeping innovative drugs from applying here in Canada. I have two questions for you, Minister. Why are you rushing to implement these regulations, which seem to be blocking new life-saving medicines from coming to Canada, and can you tell Canadians with 100% confidence that these regulatory changes will not affect Canada's drug supply?
Result: 1 - 1 of 1

Export As: XML CSV RSS

For more data options, please see Open Data